A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03096119

Acronym

Asia BP@Home

Enrollment

1462

Registered

2017-03-30

Start date

2017-04-06

Completion date

2018-03-31

Last updated

2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

blood pressure monitoring, home, Asia

Brief summary

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Detailed description

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. The main purpose of this study is to: * Assess HBP control status in each Asian country * Develop an Asian consensus and Asia-specific treatment for hypertension * Improve the management of hypertension in Asia by encouraging patients to monitor HBP

Interventions

OTHERhome blood pressure measurement

We ask participants to measure their home blood pressure 7 days or more.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age \>= 20 years 2. Subjects with stable medication (\> 3 months) diagnosed as hypertension 3. Asian 4. Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Distribution rate based on the home BP of the patients.	7 days or more blood pressure measurement	Distribution rate based on the home BP of the patients who are defined as: * Masked morning hypertension * White-coat hypertension * Poorly controlled hypertension * Well controlled hypertension

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026